Scientists at Imperial College London have developed a new cancer drug which they plan to trial in multiple myeloma patients by the end of next year.
An experimental treatment that trains a patient's immune system to attack their cancer caused remission in 90 per cent of leukaemia patients on a small-scale trial, though experts warn questions remain.
New medications created by pharmaceutical companies have helped millions of Americans alleviate pain and suffering from their medical conditions. However, the drug creation process often misses many side ...
New research has shown current practices for treating stroke victims may be leaving patients overburdened by their treatment plans putting them at risk of adverse side effects.